Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Evidence-Based Smoking Cessation Interventions Into Lung Cancer Screening Programs: A Randomized Trial

NCT03200236 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT03200236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03200236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Evidence-Based Smoking Cessation Interventions Into Lung Cancer Screening Programs: A Randomized Trial
Lead sponsor
Georgetown University
Phase
Phase 3
Overall status
Completed
Start date
May 3, 2017
Completion date
January 30, 2022
Enrollment
1,114 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer screening, smoking, tobacco, tobacco use, tobacco-related carcinoma